Both in Biotechnology
Intensity Therapeutics vs BioCardia
Over the past year INTS returned −49.9% and BCDA returned −29.3%; their daily moves had a correlation of -0.06.
INTS −49.9% BCDA −29.3%Growth of $1, one year, split-adjusted
| Metric | INTS | BCDA |
|---|---|---|
| Price | $3.34 | $0.9260 |
| Market cap | $10.9M | $14.0M |
| Today | −1.18% | −2.26% |
| 1 month | −0.9% | −8.3% |
| 6 months | −35.9% | −18.8% |
| Year to date | −67.4% | −25.9% |
| 1 year | −47.0% | −32.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.5M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.5% | 67.2% |
| Short % of float | 2.9% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).